REVIEW article
Front. Pharmacol.
Sec. Renal Pharmacology
This article is part of the Research TopicPharmacological Modulation of Inflammatory Pathways in Sepsis: Targeting the Cytokine Storm and Septic Oxidative StressView all 3 articles
Comparison of short-term and long-term renal function effects of vasopressin and norepinephrine in patients with septic shock: a systematic review and meta-analysis
Provisionally accepted
- Guangdong Medical University, Zhan Jiang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background Vasopressin and its derivatives, as second-line vasoactive agents, are increasingly being applied in the treatment of septic shock, but their effects on major organs, particularly the renal system, remain inadequately evaluated. Methods A systematic search was conducted based on 4 online databases Embase, PubMed, ScienceDirect, and Scopus, for studies published up to April 2025 that compared the renal function outcomes between vasopressin versus norepinephrine. All the studies enrolled adult patients with septic shock. Both short-term outcomes (urine output, serum creatinine levels) and long-term outcomes (acute kidney injury (AKI) rate, renal failure (RF), days free of RF, and renal replacement therapy (RRT)-use rate) were assessed. Results A total of 13 studies met the inclusion criteria, comprising 10 RCTs and 3 retrospective cohort studies, with a total of 2,024 septic shock patients (aged 46.76–68 years) engaged. Meta-analysis showed no significant differences between the vasopressin and norepinephrine groups in the incidence of AKI (Risk Ratio (RR) = 1.07, 95% CI [0.86, 1.33], P = 0.53), days free of RF (MD = 1.52, 95% CI [-2.21, 5.25], P = 0.43), incidence of RF (RR = 1.01, 95% CI [0.85, 1.19], P = 0.94), or urine output (MD = -161.93 mL, 95% CI [-690.31, 366.45], P = 0.55). However, vasopressin was associated with a significantly lower serum creatinine level (MD = -0.15 mg/dL, 95% CI [-0.29, -0.02], P = 0.028) and a reduced RRT utilization rate (RR = 0.76, 95% CI [0.62, 0.93], P < 0.01) compared to norepinephrine. Conclusion Vasopressin demonstrates potential renal protective effects in the management of septic shock, as evidenced by a significant reduction in serum creatinine levels and a decreased need for renal replacement therapy compared with norepinephrine. However, the evidence supporting its benefit in reducing the incidence of AKI and RF, or prolonging the days free of RF remains of low quality.
Keywords: vasopressin, Renal function, Norepinephrine, septic shock, Meta - analysis
Received: 20 Jul 2025; Accepted: 05 Nov 2025.
Copyright: © 2025 Wang, Liu and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Hong Zhang, 545666086@qq.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.